Advertisement
Singapore markets open in 7 hours 44 minutes
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,060.29
    -10.26 (-0.20%)
     
  • Dow

    38,396.22
    -107.47 (-0.28%)
     
  • Nasdaq

    15,684.82
    -11.82 (-0.08%)
     
  • Bitcoin USD

    64,932.12
    -1,753.84 (-2.63%)
     
  • CMC Crypto 200

    1,398.67
    -25.43 (-1.79%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Gold

    2,341.10
    -1.00 (-0.04%)
     
  • Crude Oil

    82.62
    -0.74 (-0.89%)
     
  • 10-Yr Bond

    4.6480
    +0.0500 (+1.09%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

2 COVID-19 Antibody Stocks to Buy Right Now

2 COVID-19 Antibody Stocks to Buy Right Now

Luckily, there are over 300 coronavirus treatment candidates currently in various stages of preclinical and clinical studies. If successful antibody therapeutics could be developed to treat and prevent SARS-CoV-2 infections, they could be game-changers in the fight against the disease that's caused worldwide economic shutdowns and killed almost 200,000 people in the U.S. alone. GlaxoSmithKline (NYSE: GSK) and Regeneron (NASDAQ: REGN) are two companies leading the way in developing prospective antibody treatments for COVID-19.